Journal
MOLECULAR CELL
Volume 61, Issue 6, Pages 809-820Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2016.02.032
Keywords
-
Categories
Funding
- National Research Council of Science and Technology [DRC-14-2-KRISS]
- Gordon and Betty Moore Foundation [GBMF775]
- Beckman Institute
- Vietnam Education Foundation
- International Myeloma Foundation
- Leukemia & Lymphoma Society
- HHMI
Ask authors/readers for more resources
Cereblon (CRBN), a substrate receptor for the cullin-RING ubiquitin ligase 4 (CRL4) complex, is a direct protein target for thalidomide teratogenicity and antitumor activity of immunomodulatory drugs (IMiDs). Here we report that glutamine synthetase (GS) is an endogenous substrate of CRL4(CRBN). Upon exposing cells to high glutamine concentration, GS is acetylated at lysines 11 and 14, yielding a degron that is necessary and sufficient for binding and ubiquitylation by CRL4 CRBN and degradation by the proteasome. Binding of acetylated degron peptides to CRBN depends on an intact thalidomide-binding pocket but is not competitive with IMiDs. These findings reveal a feedback loop involving CRL4 CRBN that adjusts GS protein levels in response to glutamine and uncover a new function for lysine acetylation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available